Skip to main content
. 2016 Mar 26;7(19):27243–27254. doi: 10.18632/oncotarget.8402

Figure 4. Representative microPET/CT images of mice bearing CNE-2 NPC tumors at 1 h after intravenous injection of 18F-AIF-NOTA-PRGD2 on days 0, 2, 4, 7, and 14 after treatments was initiated.

Figure 4

(A) Saline control. (B) Endostar treatment.